Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma

Published:2004 Issue:2 Volume:100 Page:356-365
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sakata Koh-ichi,Satoh Masaaki,Someya Masanori,Asanuma Hiroko,Nagakura Hisayasu,Oouchi Atushi,Nakata Kensei,Kogawa Katsuhisa,Koito Kazumitsu,Hareyama Masato,Himi Tetsuo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

2. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

3. World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on the mechanism of Euscaphic acid in the treatment of non-Hodgkin lymphoma based on network pharmacology and molecular docking;2024-02-09

2. Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting;Frontiers in Immunology;2023-09-28

3. Immunohistochemical assessment of metalloproteinases MMP2 and MMP9 expression in canine various subtypes of lymphomas in relation with proliferative and apoptotic markers;Polish Journal of Veterinary Sciences;2023-07-26

4. Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma;Upsala Journal of Medical Sciences;2023-05-09

5. Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma;Biomedicine & Pharmacotherapy;2022-06